The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2020
Historique:
received: 21 10 2020
accepted: 18 12 2020
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 27 5 2021
Statut: epublish

Résumé

Management strategies after lobectomy for low-risk papillary thyroid carcinoma (PTC) are controversial. This study aimed to identify the proportion of patients among low-risk PTC patients who do not require hormone replacement therapy and to evaluate the risk factors for postoperative hypothyroidism after lobectomy. The records of 190 PTC patients who underwent thyroid lobectomy from January 2017 to December 2018 were retrospectively reviewed. Clinicopathological characteristics and follow-up data were collected. Univariate and multivariate analyses were performed to identify the risk factors associated with postoperative hypothyroidism and the recovery of thyroid function. In summary, 74.21% of patients (141/190) had normal thyroid function without levothyroxine supplementation, while 40.53% (77/190) developed temporary or permanent hypothyroidism. Multivariate analysis indicated that higher preoperative thyroid-stimulating hormone (TSH) levels (>2.62 mIU/L), Hashimoto's thyroiditis (HT), and right lobectomy were associated with hypothyroidism (all P<0.05). The Area Under Curve (AUC) by logistic analysis was 0.829. Twenty-eight (28/77, 36.4%) patients recovered to the euthyroid state in the first year after surgery, and this recovery was significantly associated with preoperative TSH level. Forty-nine (49/77, 63.6%) patients developed persistent hypothyroidism. The thyroid function of most patients (11/28, 39.3%) recovered in the third month after surgery. Patients with a lower level of preoperative TSH, with left lobectomy and without Hashimoto's thyroiditis had a higher chance of normal thyroid function within the first year after lobectomy. The recovery of thyroid function was associated with the level of preoperative TSH.

Identifiants

pubmed: 33633689
doi: 10.3389/fendo.2020.619841
pmc: PMC7899978
doi:

Substances chimiques

Thyrotropin 9002-71-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

619841

Informations de copyright

Copyright © 2021 Dou, Chen, Hu and Su.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Neurosci. 2006 Oct;116(10):1173-9
pubmed: 16923685
Anat Rec (Hoboken). 2009 Feb;292(2):169-74
pubmed: 19051270
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):570-4
pubmed: 19155436
Ann Surg Oncol. 2014 Nov;21(12):3844-52
pubmed: 24943236
World J Surg. 2008 Nov;32(11):2503-8
pubmed: 18758850
J Clin Med. 2019 Aug 22;8(9):
pubmed: 31443521
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Endocrinol Metab Clin North Am. 2019 Mar;48(1):227-237
pubmed: 30717904
J Korean Surg Soc. 2011 Dec;81(6):380-6
pubmed: 22200038
J Surg Res. 2019 Oct;242:244-251
pubmed: 31103828
Head Neck. 2019 May;41(5):1463-1467
pubmed: 30597664
Endocrinol Metab (Seoul). 2019 Jun;34(2):150-157
pubmed: 31099202
Surgery. 2009 Oct;146(4):554-8; discussion 558-60
pubmed: 19789012
Surgery. 2018 Jan;163(1):75-80
pubmed: 29122328
Thyroid. 2017 Sep;27(9):1164-1170
pubmed: 28699428
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1317-1324
pubmed: 28324106
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Ann Surg Oncol. 2017 Jun;24(6):1525-1532
pubmed: 28058547
Ann Surg Oncol. 2011 Sep;18(9):2548-54
pubmed: 21547704
Endocrine. 2012 Oct;42(2):252-65
pubmed: 22644837
Braz J Otorhinolaryngol. 2018 Nov - Dec;84(6):729-735
pubmed: 28964693
Ann Oncol. 2019 Dec 1;30(12):1856-1883
pubmed: 31549998
Mayo Clin Proc. 2009;84(1):65-71
pubmed: 19121255
Thyroid. 2017 Aug;27(8):1011-1016
pubmed: 28657504
Thyroid. 2019 Jan;29(1):64-70
pubmed: 30375260
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Clin Oncol. 2013 Nov 10;31(32):4046-53
pubmed: 24101052
Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367
pubmed: 31812326
Am J Surg. 2012 Apr;203(4):461-6
pubmed: 21703593
Asian J Surg. 2019 Nov;42(11):957-962
pubmed: 30987945
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2468-2477
pubmed: 29850817
Ann Surg Oncol. 2019 Sep;26(9):2952-2958
pubmed: 31264119
Am J Surg. 2005 May;189(5):587-91; discussion 591
pubmed: 15862501

Auteurs

Yi Dou (Y)

Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Yingji Chen (Y)

Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Daixing Hu (D)

Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Xinliang Su (X)

Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH